Stay updated on BMN 110 Phase 3B in Australian Patients Clinical Trial

Sign up to get notified when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMN 110 Phase 3B in Australian Patients Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:56:11.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version of the study on Mucopolysaccharidosis IVA (Morquio A Syndrome), including the removal of outdated treatment information and the addition of new study details. Notably, the enzyme replacement therapy BMN 110 is now highlighted as a potential treatment option.
    Difference
    60%
    Check dated 2025-04-16T02:07:29.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T23:46:52.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T18:53:53.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T19:06:08.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T09:21:48.000Z thumbnail image

Stay in the know with updates to BMN 110 Phase 3B in Australian Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.